Overview

Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator

Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether Aspirin or Clopidogrel are effective in the prevention of venous obstruction after implantation of cardiac pacemaker or defibrillator.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Treatments:
Aspirin
Clopidogrel
Ticlopidine
Criteria
Inclusion Criteria:

- patients who referred for first implantation of pacemaker, implantable cardiac
defibrillator, or cardiac re synchronization therapy device

Exclusion Criteria:

- history of malignancy

- history of coagulopathy or platelet disorder

- history of venous thromboembolism

- history of gastrointestinal hemorrhage or active gastroduodenal ulcer in past 6 months

- history of chronic kidney disorder or serum creatinine more than 1.5 mg/dl

- patients who are on anticoagulant or other antithrombotic drugs or who must be on dual
antiplatelet therapy.